Your session is about to expire
← Back to Search
Penicillin Antibiotic
Amoxicillin for Pneumonia
Phase 2 & 3
Recruiting
Led By Jocelyn Gravel, MD
Research Sponsored by St. Justine's Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Presence of respiratory symptoms (cough and/or dyspnea)
Presence of signs of pneumonia (tachypnea, abnormal breath sounds, crackles)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 month
Awards & highlights
Study Summary
This trial will compare a twice-daily to a thrice-daily antibiotic regimen for the treatment of non-severe community acquired pneumonia in children.
Who is the study for?
This trial is for children aged 3 months to 18 years with non-severe community acquired pneumonia, showing symptoms like cough, fever, and abnormal breath sounds. They must have signs of pneumonia on a chest X-ray. Kids with severe allergic reactions to amoxicillin, chronic illnesses, or recent hospital stays are excluded.Check my eligibility
What is being tested?
The study tests if taking the antibiotic Amoxicillin twice daily is just as effective as three times daily for treating non-severe pneumonia in kids who visit the emergency department.See study design
What are the potential side effects?
Amoxicillin may cause side effects such as allergic reactions (rash), gastrointestinal issues (nausea, vomiting), and rarely more serious conditions like Stevens-Johnson syndrome.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have symptoms like coughing or difficulty breathing.
Select...
I am showing signs of pneumonia, like rapid breathing and unusual lung sounds.
Select...
I am between 3 months and 18 years old with a diagnosis of non-severe pneumonia.
Select...
I have a fever.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 month
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 month
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Clinical failure within 10 days of enrolment
Secondary outcome measures
Adverse events
Clinical recurrence
Emergency department revisit within 72 hours
+3 moreTrial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Twice a day regimenExperimental Treatment1 Intervention
Patients will received a prescription of amoxicillin (90mg/kg/day) divided in two doses daily.
Group II: Thrice a day regimenActive Control1 Intervention
Patients will received a prescription of amoxicillin (90mg/kg/day) divided in three doses daily.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Amoxicillin
2017
Completed Phase 4
~7780
Find a Location
Who is running the clinical trial?
St. Justine's HospitalLead Sponsor
196 Previous Clinical Trials
77,659 Total Patients Enrolled
Jocelyn Gravel, MDPrincipal InvestigatorSainte-Justine Hospital
5 Previous Clinical Trials
1,587 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have had serious skin reactions to amoxicillin in the past.You had a serious allergic reaction to penicillin or amoxicillin, as confirmed by your doctor.I have symptoms like coughing or difficulty breathing.I am showing signs of pneumonia, like rapid breathing and unusual lung sounds.Your doctor sees something concerning on your chest X-ray.I have had pneumonia symptoms for more than 2 weeks or have been hospitalized for pneumonia recently.I do not need hospitalization for conditions like severe infections.I am between 3 months and 18 years old with a diagnosis of non-severe pneumonia.I have severe symptoms related to pneumonia.You have taken amoxicillin in the last month.I do not have any unstable chronic illnesses like cystic fibrosis or active TB.I have a fever.
Research Study Groups:
This trial has the following groups:- Group 1: Thrice a day regimen
- Group 2: Twice a day regimen
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
What are some common diseases that Amoxicillin is known to cure?
"Amoxicillin is primarily used to treat helicobacter pylori infection, though it can also be taken for other bacterial infections, community acquired pneumonia (cap), and acute otitis media (aom)."
Answered by AI
How many volunteers are being enrolled in this experiment?
"That is correct. The information available on clinicaltrials.gov leads us to believe that this study is currently looking for participants. This trial was first posted on 6/11/2017, and the most recent update was 5/3/2022. They are hoping to enroll 1370 patients from 1 site."
Answered by AI
Are we able to enroll more individuals in this research project?
"As of right now, this study requires new participants. The original posting was on June 11th, 2017, with the most recent update being May 3rd, 2022."
Answered by AI
Are people over the age of 50 elligible for this study?
"According to the eligibility requirements listed, patients aged 3 months to 18 years old may qualify for this trial. There are 45 studies that focus on pediatrics and 196 studies targeting an elderly population."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger